Kefir induces cell-cycle arrest and apoptosis in HTLV-l-negative malignant T-lymphocytes

Cancer Management and Research

Volumn 3, Issue 1, 2011, Pages 39-47

  Maalouf, Katia ^a   Baydoun, Elias ^b   Rizk, Sandra ^a  

^a LEBANESE AMERICAN UNIVERSITY   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Apoptosis; Cancer; CEM; Jurkat; Kefir; Leukemia

Indexed keywords

GELATINASE A; GELATINASE B; KEFIR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DEATH; CELL DIVISION; CELL FREE SYSTEM; CELL PROLIFERATION; CELL VIABILITY; CHILD; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IC 50; INCUBATION TIME; LEUKEMIA CELL LINE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; UPREGULATION;

EID: 79952972804     PISSN: None     EISSN: 11791322     Source Type: Journal    
DOI: 10.2147/CMR.S15109     Document Type: Article

References (28)

1. Armitrage JO, Longo DL. Malignancies of lymphoid cells. In: Kasoer DL, Braunwald E, Fauci AS, et al, editors. Harrison's Online: Harrison's Principles of Internal Medicine. 16th ed. New York, NY: McGraw-Hill; 2005.
2. Pui C, Evans W. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;345:266-278.
3. Farnworth E. Kefir-a complex probiotic. Food Sci Technol Bull. 2005;2:1-17.
4. Liu JR, Wang SY, Lin YY, Lin CW. Antitumor activity of milk kefir and soy milk kefir in tumor-bearing mice. Nutr Cancer. 2002;44:182-187.
5. Kubow S, Chan LH, Chen C, Fotouhinia M. World Intellectual Property Organization. Kefir extract as anti-cancer agent. Geneva, Switzerland: World Intellectual Property Organization; 2001;WO/2001/09591.
6. Lopitz-Otsoa F, Rementeria A, Elguezabal N, Garaizar J. Kef ir: a symbiotic yeasts-bacteria community with alleged healthy capabilities. Rev Iberoam Micol. 2006;23:67-74.
7. Abraham A, de Antoni G. Characterization of kefir grains grown in cows' milk and in soya milk. J Dairy Res. 1998;66:327-333.
8. Lee MY, Ahn KS, Kwon OK, et al. Anti-inflammatory and anti-allergic effects of kefir in a mouse asthma model. Immunobiology. 2007;212: 47-654.
9. Thoreux K, Schmucker DL. Kefir milk enhances intestinal immunity in young but not old rats. J Nutr. 2001;131:807-812.
10. De Vrese M, Keller B, Barth CA. Enhancement of intestinal hydrolysis of lactose by microbial b-galactosidase (EC 3.2.1.23) of kefir. Br J Nutr. 1992;67:67-75.
11. Garrote GL, Abraham AG, de Antoni GL. Preservation of kefir grains, a comparative study. Lebenson Wiss Technol. 1997;30:77-84.
12. Liu JR, Wang SY, Chen MJ, Yueh PY, Lin CW. The anti-allergenic properties of milk kefir and soymilk kefir and their beneficial effects on the intestinal microflora. J Sci Food Agricul. 2006;86:2527-2533.
13. Marquina D, Santos A, Corpas I, Munoz J, Zazo J, Pienado JM. Dietary influence of kefir on microbial activities in the mouse bowel. Lett Appl Microbiol. 2002;35:136-140.
14. Guzel-Seydem ZB, Seydem AC, Greene AK, Tas T. Determination of antimutagenic properties of acetone extracted fermented milks and changes in their total fatty acid profiles including conjugated linoleic acids. Int J Dairy Technol. 2006;59:209-215.
15. LeBlanc A, Matar C, Farnworth E, Perdigon G. Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir. Cytokine. 2006;34:1-8.
16. Shiomi M, Sasaki K, Murofushi M, Aibara K. Antitumor activity in mice of orally administered polysaccharide from kefir grain. Jpn J Med Sci Biol. 1982;35:75-80.
17. Furuwaka N, Matsuoka A, Takahashi T, Yamanaka Y. Anti-metastatic effect of kefir grain components on Lewis Lung Carcinoma and highly metastatic B16 melanoma in mice. J Agricult Sci. 2000;45:62-70.
18. Chen C, Chan HM, Kubow S. Kefir extracts suppress in vitro proliferation of estrogen-dependent human breast cancer cells but not normal mammary epithelial cells. J Med Food. 2007;10:416-422.
19. Rizk S, Maalouf K, Baydoun E. The anti-proliferative effect of kefir cellfree fraction on HuT-102 malignant T-lymphocytes. Clin Lymphoma Myeloma Leuk. 2009:S198-S203.
20. Foley GE, Lazarus H, Farber S, Uzman BG, Boone BA, Mccarthy RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. 1965;18:522-529.
21. Harakeh S, Diab-Assaf M, Niedzwiecki A, Khalife J, Abu-El-Ardat K, Rath M. Apoptosis induction by Epican Forte in HTLV-1 positive and negative malignant T-cells. Leuk Res. 2006;30:869-881.
22. Jorissen RN, Walker F, Pouliot N, Garrett, TPJ, Ward CW, Burgess AW. Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res. 2003;284:31-53.
23. Kanai M, Konda Y, Nakajima T, Izumi Y, Takeuchi T, Chiba T. TGF-α inhibits apoptosis of murine gastric pit cells through an NF-κBdependent pathway. Gastroenterology. 2001;121:56-67.
24. Harris RC, Chung E, Coffey RJ. EGF Receptor ligands. Exp Cell Res. 2003;284:2-13.
25. Saeki K, et al. Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor beta 1 and overexpression of Bcl-2. J Biol Chem. 2000;272:3-10.
26. Cerwenka A, Kovar H, Majdic O, Holter W. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-beta 1. J Immunol. 1996;156:459-464.
27. + T cells. J Exp Med. 1998;188: 1849-1857.
28. Patil S, et al. Smad7 is induced by CD40 and protects WEHI 231 B-lymphocytes from transforming growth factor-b-induced growth inhibition and apoptosis. J Biol Chem. 2000;275:38363-38370.